Multiple System Atrophy Latest Advances

Structural biology of alpha-synuclein amyloid ﬁlaments: Implications in synucleinopathies.

Journal: Journal of Parkinson's disease

Published: June 19, 2026

FDG PET in Movement Disorders and Parkinsonian Syndromes.

Journal: PET clinics

Published: June 18, 2026

Pathology and Genetics in a Global Cohort of Parkinsonian Disorders.

Journal: JAMA neurology

Published: June 08, 2026

Correction to: Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.

Journal: Brain : a journal of neurology

Published: June 02, 2026

Cerebral metabolic trajectories alterations in multiple system atrophy: A longitudinal FDG-PET study.

Journal: Journal of Parkinson's disease

Published: May 28, 2026

The PET tracer [11C]MODAG-005 targets alpha-synuclein aggregates in the brain.

Journal: Science translational medicine

Published: May 27, 2026

Adaptation of α-synuclein fibrils following multiple system atrophy transmission to mice.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

Distinct Sympathoneural and Cardiovagal Domains of Arterial Baroreflex Function in Autonomic Synucleinopathies.

Journal: Research square

Published: May 25, 2026

Safety, Feasibility, and Efficacy of Immersive Virtual Reality Training With a Body Weight Support System for Patients With Extrapyramidal Disorders: A Pilot Case Series Study.

Journal: Cureus

Published: May 21, 2026

α-synuclein PET imaging: early human evidence and the path toward clinical proof-of-concept.

Journal: Expert review of molecular diagnostics

Published: May 14, 2026

Characterization and evaluation of the ability of graphene quantum dots to affect α-synuclein aggregation in synucleinopathy models.

Journal: Science and technology of advanced materials

Published: May 13, 2026

Development of an Interpretable Deep Learning-Based Segmentation Algorithm for Automated Assessment of Oral Diadochokinesis in Progressive Neurological Diseases.

Journal: Journal of speech, language, and hearing research : JSLHR

Published: May 11, 2026

Multiple System Atrophy Latest Advances

Find the Latest Research About Multiple System Atrophy

Structural biology of alpha-synuclein amyloid ﬁlaments: Implications in synucleinopathies.

Structural biology of alpha-synuclein amyloid ﬁlaments: Implications in synucleinopathies.

FDG PET in Movement Disorders and Parkinsonian Syndromes.

FDG PET in Movement Disorders and Parkinsonian Syndromes.

Pathology and Genetics in a Global Cohort of Parkinsonian Disorders.

Pathology and Genetics in a Global Cohort of Parkinsonian Disorders.

Correction to: Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.

Correction to: Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.

Cerebral metabolic trajectories alterations in multiple system atrophy: A longitudinal FDG-PET study.

Cerebral metabolic trajectories alterations in multiple system atrophy: A longitudinal FDG-PET study.

The PET tracer [11C]MODAG-005 targets alpha-synuclein aggregates in the brain.

The PET tracer [11C]MODAG-005 targets alpha-synuclein aggregates in the brain.

Adaptation of α-synuclein fibrils following multiple system atrophy transmission to mice.

Adaptation of α-synuclein fibrils following multiple system atrophy transmission to mice.

Distinct Sympathoneural and Cardiovagal Domains of Arterial Baroreflex Function in Autonomic Synucleinopathies.

Distinct Sympathoneural and Cardiovagal Domains of Arterial Baroreflex Function in Autonomic Synucleinopathies.

Safety, Feasibility, and Efficacy of Immersive Virtual Reality Training With a Body Weight Support System for Patients With Extrapyramidal Disorders: A Pilot Case Series Study.

Safety, Feasibility, and Efficacy of Immersive Virtual Reality Training With a Body Weight Support System for Patients With Extrapyramidal Disorders: A Pilot Case Series Study.

α-synuclein PET imaging: early human evidence and the path toward clinical proof-of-concept.

α-synuclein PET imaging: early human evidence and the path toward clinical proof-of-concept.

Characterization and evaluation of the ability of graphene quantum dots to affect α-synuclein aggregation in synucleinopathy models.

Characterization and evaluation of the ability of graphene quantum dots to affect α-synuclein aggregation in synucleinopathy models.

Development of an Interpretable Deep Learning-Based Segmentation Algorithm for Automated Assessment of Oral Diadochokinesis in Progressive Neurological Diseases.

Development of an Interpretable Deep Learning-Based Segmentation Algorithm for Automated Assessment of Oral Diadochokinesis in Progressive Neurological Diseases.